Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Medigene ( (DE:MDG1) ) is now available.
Medigene AG has announced a new total number of voting rights, now amounting to 14,887,594, effective from February 18, 2025. This announcement reflects a capital measure under Article 41 of the WpHG, potentially impacting shareholders and stakeholders by altering the distribution of voting power within the company.
More about Medigene
Medigene AG is a biotechnology company based in Planegg/Martinsried, Germany. The company operates in the regulated markets of Frankfurt and free markets across several German cities, focusing on innovative therapeutic solutions.
YTD Price Performance: 54.00%
Average Trading Volume: 928
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €13.74M
See more data about MDG1 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue